Cargando…

The Production of the Oral Mucosa of Antiendomysial and Anti—Tissue-Transglutaminase Antibodies in Patients with Celiac Disease: A Review

Celiac disease (CD) is a lifelong, T cell—mediated enteropathy, triggered by the ingestion of gluten and related prolamins in genetically susceptible subjects, resulting in minor intestinal mucosal injury, including villous atrophy with crypt hyperplasia and intraepithelial lymphocytosis, and subseq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Compilato, Domenico, Campisi, Giuseppina, Pastore, Luca, Carroccio, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763970/ https://www.ncbi.nlm.nih.gov/pubmed/21170489 http://dx.doi.org/10.1100/tsw.2010.228

Ejemplares similares

Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
por: Iervasi, Erika, et al.
Publicado: (2023)

Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2017)

Oral self-injuries: Clinical findings in a series of 19 patients
por: Cannavale, Rosangela, et al.
Publicado: (2015)

Lack of association between celiac disease and dental enamel hypoplasia in a case-control study from an Italian central region
por: Procaccini, Maurizio, et al.
Publicado: (2007)

Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009)

Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables
por: Panzarella, Vera, et al.
Publicado: (2014)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease
por: Taneja, Kanchan, et al.
Publicado: (2021)

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2
por: du Pré, M. Fleur, et al.
Publicado: (2019)

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease
por: Hawamdeh, Hasan, et al.
Publicado: (2016)

Tissue Transglutaminase Antibody and Its Association with Duodenal Biopsy in Diagnosis of Pediatric Celiac Disease
por: Meena, Daleep K., et al.
Publicado: (2019)

Relationship of citrulline and tissue transglutaminase antibody with duodenal histopathology among children with celiac disease()
por: Rahmani, Parisa, et al.
Publicado: (2022)

Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up
por: Farina, Elisa, et al.
Publicado: (2021)

Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy
por: Lindstad, Christian B., et al.
Publicado: (2022)

Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2020)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Erratum to “Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease”
por: Hawamdeh, Hasan, et al.
Publicado: (2019)

Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran
por: Sharifi, Nasrin, et al.
Publicado: (2008)

Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes
por: Kaur, Navchetan, et al.
Publicado: (2019)

Effect of helicobacter pylori infection eradication on serum level of anti-tissue transglutaminase in children with celiac disease
por: Rohani, Pejman, et al.
Publicado: (2023)

Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues
por: Dutta, Rimlee, et al.
Publicado: (2022)

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
por: Kaunisto, Helka, et al.
Publicado: (2022)

Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
por: Cerqueiro Bybrant, Mara, et al.
Publicado: (2020)

Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells
por: Paolella, Gaetana, et al.
Publicado: (2013)

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up
por: Miró, Marta, et al.
Publicado: (2021)

Variability of anti-human transglutaminase testing in celiac disease across Mediterranean countries
por: Smarrazzo, Andrea, et al.
Publicado: (2017)

Can a Synbiotic Supplementation Contribute to Decreasing Anti-Tissue Transglutaminase Levels in Children with Potential Celiac Disease?
por: Demiroren, Kaan
Publicado: (2020)

The importance of anti-transglutaminase IgA antibody detection in the diagnosis of celiac disease – case report of an inappropriate diagnostic approach
por: Szymańska, Edyta, et al.
Publicado: (2015)

Serum and salivary tissue transglutaminase IGA (tTG-IGA) level in celiac patients
por: Ajdani, Mehran, et al.
Publicado: (2022)

LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection
por: Rusanen, Juuso, et al.
Publicado: (2019)

Anti Transglutaminase Antibodies Cause Ataxia in Mice
por: Boscolo, Sabrina, et al.
Publicado: (2010)

Anti-thyroid antibodies, parietal cell antibodies and tissue transglutaminase antibodies in patients with autoimmune thyroid disease
por: Twito, Orit, et al.
Publicado: (2016)

Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity
por: Anjum, Naheed, et al.
Publicado: (2009)

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020)

Mucosal Molecular Pattern of Tissue Transglutaminase and Interferon Gamma in Suspected Seronegative Celiac Disease at Marsh 1 and 0 Stages
por: Ierardi, Enzo, et al.
Publicado: (2015)

Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity
por: Marwaha, R.K., et al.
Publicado: (2013)

Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
por: Nurmi, Rakel, et al.
Publicado: (2021)

A194 THE ADDITION OF DEAMIDATED GLIADIN PEPTIDE TO TISSUE TRANSGLUTAMINASE ANTIBODIES DOES NOT INCREASE THE ODDS OF CELIAC DISEASE DIAGNOSIS IN AN IGA SUFFICIENT POPULATION
por: Moss, K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6p88ii9is1un3jv9mfcrk8sbs5